{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T19:32:18Z","timestamp":1788118338549,"version":"build-2803163510"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100010882","name":"Tianjin Municipal Education Committee","doi-asserted-by":"publisher","award":["2022KJ253"],"award-info":[{"award-number":["2022KJ253"]}],"id":[{"id":"10.13039\/501100010882","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010104","name":"Tianjin Medical University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jtha.2025.09.015","type":"journal-article","created":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T01:09:43Z","timestamp":1760144983000},"page":"216-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1\u03b2 and impact on stroke risk in clinical cohorts"],"prefix":"10.1016","volume":"24","author":[{"given":"Guangshuai","family":"Teng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghui","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuhui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Tse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory Y.H.","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0482-0738","authenticated-orcid":false,"given":"Tong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7493-8347","authenticated-orcid":false,"given":"Jie","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2025.09.015_bib1","doi-asserted-by":"crossref","first-page":"3479","DOI":"10.1016\/j.jtha.2024.06.029","article-title":"Anticoagulation for splanchnic vein thrombosis in myeloproliferative neoplasms: a systematic review and meta-analysis","volume":"22","author":"Chrysafi","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jtha.2025.09.015_bib2","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.thromres.2022.02.006","article-title":"Thrombosis in patients with post-polycythemia vera myelofibrosis: incidence and risk factors","volume":"212","author":"Teng","year":"2022","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.015_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41408-018-0048-9","article-title":"Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms","volume":"8","author":"De Stefano","year":"2018","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtha.2025.09.015_bib4","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/s41408-024-01169-6","article-title":"Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors","volume":"14","author":"Barbui","year":"2024","journal-title":"Blood Cancer J"},{"key":"10.1016\/j.jtha.2025.09.015_bib5","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1002\/ajh.27002","article-title":"Polycythemia vera: 2024 update on diagnosis, risk-stratification, and management","volume":"98","author":"Tefferi","year":"2023","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jtha.2025.09.015_bib6","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.semcancer.2025.02.007","article-title":"Clonal hematopoiesis, cardiovascular disease and cancer treatment-induced cardiotoxicity","volume":"111","author":"Zhang","year":"2025","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.jtha.2025.09.015_bib7","doi-asserted-by":"crossref","DOI":"10.1172\/JCI168597","article-title":"Genetic modification of inflammation- and clonal hematopoiesis-associated cardiovascular risk","volume":"133","author":"Yu","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.09.015_bib8","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"key":"10.1016\/j.jtha.2025.09.015_bib9","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1158\/2159-8290.CD-22-0952","article-title":"Jak2V617F reversible activation shows its essential requirement in myeloproliferative neoplasms","volume":"14","author":"Dunbar","year":"2024","journal-title":"Cancer Discov"},{"key":"10.1016\/j.jtha.2025.09.015_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.thromres.2023.04.021","article-title":"Atrial fibrillation and peripheral arterial disease define MPN patients with very high risk of thrombosis","volume":"226","author":"Herbreteau","year":"2023","journal-title":"Thromb Res"},{"key":"10.1016\/j.jtha.2025.09.015_bib11","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1182\/blood.2022015850","article-title":"International consensus classification of myeloid neoplasms and acute leukemias: integrating morphologic, clinical, and genomic data","volume":"140","author":"Arber","year":"2022","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2025.09.015_bib12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/s41375-023-02069-7","article-title":"ASXL1 mutation is a novel risk factor for bleeding in Philadelphia-negative myeloproliferative neoplasms","volume":"38","author":"Awada","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2025.09.015_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41375-023-02114-5","article-title":"Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification","volume":"38","author":"Pasquer","year":"2024","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2025.09.015_bib14","first-page":"2388","article-title":"Characterization and prognostic implication of pulmonary hypertension among patients with myeloproliferative neoplasms","volume":"110","author":"Leiva","year":"2025","journal-title":"Haematologica"},{"key":"10.1016\/j.jtha.2025.09.015_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurheartj\/ehad670","article-title":"Clonal haematopoiesis of indeterminate potential predicts incident cardiac arrhythmias","volume":"45","author":"Schuermans","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.09.015_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1093\/eurheartj\/ehad869","article-title":"Clonal haematopoiesis of indeterminate potential and atrial fibrillation: an east Asian cohort study","volume":"45","author":"Ahn","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jtha.2025.09.015_bib17","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1038\/s41375-020-0891-0","article-title":"The Janus kinase 1\/2 inhibitor ruxolitinib in COVID-19 with severe systemic hyperinflammation","volume":"34","author":"La Ros\u00e9e","year":"2020","journal-title":"Leukemia"},{"key":"10.1016\/j.jtha.2025.09.015_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167517","article-title":"Chronic kidney disease promotes atrial fibrillation via inflammasome pathway activation","volume":"133","author":"Song","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jtha.2025.09.015_bib19","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1161\/CIRCULATIONAHA.118.035202","article-title":"Enhanced cardiomyocyte NLRP3 inflammasome signaling promotes atrial fibrillation","volume":"138","author":"Yao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.09.015_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/imr.12621","article-title":"Overview of the IL-1 family in innate inflammation and acquired immunity","volume":"281","author":"Dinarello","year":"2018","journal-title":"Immunol Rev"},{"key":"10.1016\/j.jtha.2025.09.015_bib21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/s41572-022-00347-9","article-title":"Atrial fibrillation","volume":"8","author":"Brundel","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/j.jtha.2025.09.015_bib22","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1161\/CIRCULATIONAHA.123.065597","article-title":"Clonal hematopoiesis of indeterminate potential with loss of Tet2 enhances risk for atrial fibrillation through Nlrp3 inflammasome activation","volume":"149","author":"Lin","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.jtha.2025.09.015_bib23","doi-asserted-by":"crossref","first-page":"8102","DOI":"10.1038\/s41467-023-43697-y","article-title":"Clonal hematopoiesis related TET2 loss-of-function impedes IL1\u03b2-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells","volume":"14","author":"McClatchy","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jtha.2025.09.015_bib24","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.120.049715","article-title":"Circular RNA CircMAP3K5 acts as a microRNA-22-3p sponge to promote resolution of intimal hyperplasia via TET2-mediated smooth muscle cell differentiation","volume":"143","author":"Zeng","year":"2021","journal-title":"Circulation"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783625006063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:01:13Z","timestamp":1768456873000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783625006063"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S1538783625006063"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.015","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TET2 mutations in myeloproliferative neoplasms: potential mediation of atrial fibrillation by interleukin-1\u03b2 and impact on stroke risk in clinical cohorts","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2025.09.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}